Kayla Rodriguez Graff is the co-founder and CEO of SweetBio, a Memphis-based medical device company bioengineering Manuka honey, collagen, and hydroxyapatite into FDA-cleared, Medicare-covered wound care products (APIS and VERIS). She runs the company with her brother, scientist Dr. Isaac Rodriguez, and has raised more than $10M to expand access to affordable wound care, especially in communities hit hardest by diabetes.

Tiffany Luck is a Partner at NEA (New Enterprise Associates), one of the world's largest and oldest venture capital firms, where she focuses on early-stage investments in AI, APIs, and B2B SaaS. Previously a Partner at GGV Capital (now Notable Capital), she brings deep experience across enterprise software, fintech, and the AI application layer. Tiffany has a rare blend of operating, banking, and investing experience - having worked at Forbes, Amazon, and Morgan Stanley before entering venture. She is known for backing founders obsessed with their problems and for her thesis around vertical AI closing the 'last mile' gap that horizontal LLMs leave wide open.